Phase 3 study of platinum-based chemotherapy with or without pembrolizumab for first-line metastatic, nonsquamous non-small cell lung carcinoma (NSCLC): KEYNOTE-189.

被引：3

作者：

Hall, Richard Delmar

Gadgeel, Shirish M.

Garon, Edward B.

Bria, Emilio

Reck, Martin

Vida, John

Zhou, Honghong

Raftopoulos, Harry

Gandhi, Leena

机构：

[1] Univ Virginia, Charlottesville, VA USA

[2] Karmanos Canc Inst, Detroit, MI USA

[3] UCLA, David Geffen Sch Med, Los Angeles, CA USA

[4] Univ Verona, I-37100 Verona, Italy

[5] German Ctr Lung Res DZL, ARCN, Lungen Clin Grosshansdorf, Grosshansdorf, Germany

[6] Merck & Co Inc, Kenilworth, NJ USA

[7] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.TPS9104

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS9104

引用

页数：3